TrialThe American journal of pathology2013

The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes.

Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.